Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)

NCT04439643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-09-13

No results posted yet for this study

Summary

Develop time-to-event prediction and plaque phenotype classification models for patients with known or suspected coronary artery disease.

Conditions

Interventions

DEVICE

vascuCAP

time to event and phenotype classification model

Sponsors & Collaborators

  • Medical University of South Carolina

    collaborator OTHER
  • Elucid Bioimaging Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew J. Buckler, MS · Elucid Bioimaging Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2022-02-28
Completion
2022-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439643 on ClinicalTrials.gov